Literature DB >> 20384701

Prefabricated zirconium dioxide implant abutments for single-tooth replacement in the posterior region: evaluation of peri-implant tissues and superstructures after 12 months of function.

Frank Nothdurft1, Peter Pospiech.   

Abstract

AIM: In the present study, prefabricated abutments made of zirconium dioxide Y-TZP (tetragonal zirconia polycrystals) were inserted into the posterior region under controlled clinical conditions. The aim was to test whether abutments made of zirconium dioxide are suitable for this indication. Investigation parameters included reactions of peri-implant tissue and the structural integrity of the all-ceramic superstructures on the implants. Results after 12 months in function are reported in this article.
MATERIAL AND METHODS: Forty implants of the XiVE S plus screw-type implants (DENTSPLY Friadent) were inserted into the posterior region of 24 patients. After the healing period, the implants were provided with all-ceramic abutments made of zirconium dioxide Y-TZP (FRIADENT CERCON Abutment; DENTSPLY Friadent). All-ceramic crowns (CERCON smart ceramics; DENTSPLY DeguDent) were used as superstructures and cemented using the conventional method. The following parameters were used to document the state of soft tissue: modified plaque index (mPI), sulcus fluid flow rate (SFFR, Periotron; Oraflow Inc), modified sulcus bleeding index (mSBI) and pocket depth (ST). Mesial and distal bone levels were determined on radiographs during the prosthetic treatment and at the 12-month recall. The Periotest (Medizintechnik Gulden) was used to determine implant stability.
RESULTS: All implants could be followed up after 12 months in function. In the presence of good oral hygiene (mPI: 0.5), the parameters SFFR (18) and mSBI (0.5) were indicative of stable and healthy soft tissue. ST was highest at the distal points of measurement (2.3 mm) and was generally at a low level. Compared with the baseline situation, proximal bone defects were reduced from -1.1 to -1 mm during the 12-month period of functioning. The mean Periost values at the 12-month recall were -1.9 in the maxilla and -3.8 in the mandible. Neither implant loss nor crown fractures occurred. Chipping of parts of the veneering ceramic was registered in four cases (10%).
CONCLUSION: After 12 months of wear, no mechanical failure was registered in any of the all-ceramic abutments. On clinical investigation, the peri-implant hard and soft tissues were largely healthy and devoid of inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20384701     DOI: 10.1111/j.1600-0501.2009.01899.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  5 in total

1.  Comparison of pro-inflammatory cytokines and bone metabolism mediators around titanium and zirconia dental implant abutments following a minimum of 6 months of clinical function.

Authors:  Christopher A Barwacz; Kim A Brogden; Clark M Stanford; Deborah V Dawson; Erica N Recker; Derek Blanchette
Journal:  Clin Oral Implants Res       Date:  2014-01-13       Impact factor: 5.977

2.  Fracture behavior of zirconia implant abutments is influenced by superstructure-geometry.

Authors:  Frank P Nothdurft; Konrad Neumann; Andreas W Knauber
Journal:  Clin Oral Investig       Date:  2013-09-20       Impact factor: 3.573

3.  Clinical outcomes of zirconia-based implant- and tooth-supported single crowns.

Authors:  Farahnaz Nejatidanesh; Hedayat Moradpoor; Omid Savabi
Journal:  Clin Oral Investig       Date:  2015-04-25       Impact factor: 3.573

Review 4.  Influence of implant location on the clinical outcomes of implant abutments: a systematic review and meta-analysis.

Authors:  Amr G ElHoussiney; He Zhang; Jinlin Song; Ping Ji; Lu Wang; Sheng Yang
Journal:  Clin Cosmet Investig Dent       Date:  2018-02-26

5.  Zirconia implant abutments supporting single all-ceramic crowns in anterior and premolar regions: A six-year retrospective study.

Authors:  Jo-Yu Chen; Yu-Hwa Pan
Journal:  Biomed J       Date:  2019-11-01       Impact factor: 4.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.